ID   RBM20_RAT               Reviewed;        1207 AA.
AC   E9PT37; C1IEE3;
DT   31-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   05-APR-2011, sequence version 1.
DT   29-MAY-2024, entry version 74.
DE   RecName: Full=RNA-binding protein 20 {ECO:0000305};
DE   AltName: Full=RNA-binding motif protein 20 {ECO:0000305};
GN   Name=Rbm20 {ECO:0000303|PubMed:22466703, ECO:0000312|RGD:1307427};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=Brown Norway;
RX   PubMed=22466703; DOI=10.1038/nm.2693;
RA   Guo W., Schafer S., Greaser M.L., Radke M.H., Liss M., Govindarajan T.,
RA   Maatz H., Schulz H., Li S., Parrish A.M., Dauksaite V., Vakeel P.,
RA   Klaassen S., Gerull B., Thierfelder L., Regitz-Zagrosek V., Hacker T.A.,
RA   Saupe K.W., Dec G.W., Ellinor P.T., MacRae C.A., Spallek B., Fischer R.,
RA   Perrot A., Ozcelik C., Saar K., Hubner N., Gotthardt M.;
RT   "RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing.";
RL   Nat. Med. 18:766-773(2012).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-963; SER-1057; SER-1096;
RP   SER-1101 AND SER-1192, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [4]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23307558; DOI=10.1093/nar/gks1362;
RA   Li S., Guo W., Dewey C.N., Greaser M.L.;
RT   "Rbm20 regulates titin alternative splicing as a splicing repressor.";
RL   Nucleic Acids Res. 41:2659-2672(2013).
RN   [5]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=24367651; DOI=10.1371/journal.pone.0084281;
RA   Guo W., Pleitner J.M., Saupe K.W., Greaser M.L.;
RT   "Pathophysiological defects and transcriptional profiling in the
RT   RBM20-/- rat model.";
RL   PLoS ONE 8:e84281-e84281(2013).
RN   [6]
RP   FUNCTION.
RX   PubMed=24960161; DOI=10.1172/jci74523;
RA   Maatz H., Jens M., Liss M., Schafer S., Heinig M., Kirchner M., Adami E.,
RA   Rintisch C., Dauksaite V., Radke M.H., Selbach M., Barton P.J., Cook S.A.,
RA   Rajewsky N., Gotthardt M., Landthaler M., Hubner N.;
RT   "RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-
RT   mRNA processing.";
RL   J. Clin. Invest. 124:3419-3430(2014).
RN   [7]
RP   FUNCTION.
RX   PubMed=25573899; DOI=10.1093/jmcb/mjv002;
RA   Zhu C., Yin Z., Ren J., McCormick R.J., Ford S.P., Guo W.;
RT   "RBM20 is an essential factor for thyroid hormone-regulated titin isoform
RT   transition.";
RL   J. Mol. Cell Biol. 7:88-90(2015).
RN   [8]
RP   FUNCTION.
RX   PubMed=27289039; DOI=10.1002/1873-3468.12251;
RA   Ito J., Iijima M., Yoshimoto N., Niimi T., Kuroda S., Maturana A.D.;
RT   "RBM20 and RBM24 cooperatively promote the expression of short enh splice
RT   variants.";
RL   FEBS Lett. 590:2262-2274(2016).
RN   [9]
RP   FUNCTION.
RX   PubMed=33805770; DOI=10.3390/ijms22062928;
RA   Maimaiti R., Zhu C., Zhang Y., Ding Q., Guo W.;
RT   "RBM20-mediated pre-mRNA splicing has muscle-specificity and differential
RT   hormonal responses between muscles and in muscle cell cultures.";
RL   Int. J. Mol. Sci. 22:0-0(2021).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION AT SER-638; SER-640;
RP   SER-643; SER-645; SER-652; SER-729; SER-789; SER-879; SER-881; SER-999;
RP   SER-1034; SER-1046; SER-1057; SER-1096; SER-1190 AND SER-1192, AND
RP   MUTAGENESIS OF SER-638; SER-640; SER-643; SER-645; SER-652; SER-729;
RP   SER-789; SER-879; SER-881; SER-999; SER-1034; SER-1046; SER-1057; SER-1096;
RP   SER-1190 AND SER-1192.
RX   PubMed=35394688; DOI=10.1096/fj.202101811rr;
RA   Zhang Y., Wang C., Sun M., Jin Y., Braz C.U., Khatib H., Hacker T.A.,
RA   Liss M., Gotthardt M., Granzier H., Ge Y., Guo W.;
RT   "RBM20 phosphorylation and its role in nucleocytoplasmic transport and
RT   cardiac pathogenesis.";
RL   FASEB J. 36:e22302-e22302(2022).
CC   -!- FUNCTION: RNA-binding protein that acts as a regulator of mRNA splicing
CC       of a subset of genes encoding key structural proteins involved in
CC       cardiac development, such as TTN (Titin), CACNA1C, CAMK2D or PDLIM5/ENH
CC       (PubMed:22466703, PubMed:23307558, PubMed:24367651, PubMed:24960161,
CC       PubMed:25573899, PubMed:27289039, PubMed:33805770, PubMed:35394688).
CC       Acts as a repressor of mRNA splicing: specifically binds the 5'UCUU-3'
CC       motif that is predominantly found within intronic sequences of pre-
CC       mRNAs, leading to the exclusion of specific exons in target transcripts
CC       (PubMed:23307558, PubMed:24367651, PubMed:24960161, PubMed:25573899).
CC       RBM20-mediated exon skipping is hormone-dependent and is essential for
CC       TTN isoform transition in both cardiac and skeletal muscles
CC       (PubMed:23307558, PubMed:24367651, PubMed:24960161, PubMed:25573899,
CC       PubMed:33805770, PubMed:35394688). RBM20-mediated exon skipping of TTN
CC       provides substrates for the formation of circular RNA (circRNAs) from
CC       the TTN transcripts (By similarity). Together with RBM24, promotes the
CC       expression of short isoforms of PDLIM5/ENH in cardiomyocytes
CC       (PubMed:27289039). {ECO:0000250|UniProtKB:Q5T481,
CC       ECO:0000269|PubMed:22466703, ECO:0000269|PubMed:23307558,
CC       ECO:0000269|PubMed:24367651, ECO:0000269|PubMed:24960161,
CC       ECO:0000269|PubMed:25573899, ECO:0000269|PubMed:27289039,
CC       ECO:0000269|PubMed:33805770, ECO:0000269|PubMed:35394688}.
CC   -!- SUBUNIT: Associates with components of the U1 and U2 U1 small nuclear
CC       ribonucleoprotein complexes. {ECO:0000250|UniProtKB:Q5T481}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00130,
CC       ECO:0000269|PubMed:23307558, ECO:0000269|PubMed:35394688}. Cytoplasm,
CC       Cytoplasmic ribonucleoprotein granule {ECO:0000269|PubMed:35394688}.
CC       Note=The active form that regulates alternative splicing localizes to
CC       the nucleus (PubMed:35394688). Also localizes to cytoplasmic
CC       ribonucleoprotein granules; localization to cytoplasmic
CC       ribonucleoprotein granules plays an important regulatory role (By
CC       similarity). Subcellular localization is regulated by phosphorylation
CC       of different parts of the protein: while phosphorylation of the RS
CC       (arginine/serine-rich) region promotes nuclear localization,
CC       phosphorylation of the C-terminal disordered region promotes
CC       localization to cytoplasmic ribonucleoprotein granules
CC       (PubMed:35394688). {ECO:0000250|UniProtKB:Q5T481,
CC       ECO:0000269|PubMed:35394688}.
CC   -!- PTM: Phosphorylation regulates the subcellular localization.
CC       Phosphorylation of Ser-638 and Ser-640 in the RS (arginine/serine-rich)
CC       region promotes nuclear localization of the protein (PubMed:35394688).
CC       In contrast, phosphorylation of the C-terminal disordered region
CC       promotes localization to cytoplasmic ribonucleoprotein granules (By
CC       similarity). {ECO:0000250|UniProtKB:Q5T481,
CC       ECO:0000269|PubMed:35394688}.
CC   -!- DISRUPTION PHENOTYPE: Heterozygous or homozygous adults display left
CC       ventricular dilatation (PubMed:22466703, PubMed:24367651). Left
CC       ventricular diastolic diameters are significantly larger, although
CC       there is no differences in the systolic ventricular dimensions or
CC       contractility indices (PubMed:22466703). Subendocardial fibrosis
CC       increases with age and was accompanied by electrical abnormalities,
CC       such as widening of the QRS complex, atrioventricular conduction delay
CC       and a predisposition to arrhythmia (PubMed:22466703). Rats are at risk
CC       of sudden death caused by heart failure (PubMed:22466703,
CC       PubMed:24367651). {ECO:0000269|PubMed:22466703,
CC       ECO:0000269|PubMed:24367651}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EU562301; ACD80091.1; -; mRNA.
DR   RefSeq; NP_001101081.2; NM_001107611.2.
DR   AlphaFoldDB; E9PT37; -.
DR   SMR; E9PT37; -.
DR   STRING; 10116.ENSRNOP00000051570; -.
DR   iPTMnet; E9PT37; -.
DR   PhosphoSitePlus; E9PT37; -.
DR   PaxDb; 10116-ENSRNOP00000051570; -.
DR   Ensembl; ENSRNOT00000054685.3; ENSRNOP00000051570.2; ENSRNOG00000014705.7.
DR   GeneID; 309544; -.
DR   KEGG; rno:309544; -.
DR   UCSC; RGD:1307427; rat.
DR   AGR; RGD:1307427; -.
DR   CTD; 282996; -.
DR   RGD; 1307427; Rbm20.
DR   eggNOG; ENOG502QW62; Eukaryota.
DR   GeneTree; ENSGT01030000234642; -.
DR   HOGENOM; CLU_007364_0_0_1; -.
DR   InParanoid; E9PT37; -.
DR   OMA; PTRADWG; -.
DR   OrthoDB; 4268218at2759; -.
DR   TreeFam; TF333921; -.
DR   PRO; PR:E9PT37; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000014705; Expressed in heart and 16 other cell types or tissues.
DR   GO; GO:0036464; C:cytoplasmic ribonucleoprotein granule; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; IBA:GO_Central.
DR   GO; GO:0097157; F:pre-mRNA intronic binding; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; ISS:UniProtKB.
DR   GO; GO:1990935; F:splicing factor binding; ISS:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0060914; P:heart formation; IDA:UniProtKB.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; IDA:UniProtKB.
DR   GO; GO:0033120; P:positive regulation of RNA splicing; ISO:RGD.
DR   GO; GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IDA:UniProtKB.
DR   GO; GO:0048024; P:regulation of mRNA splicing, via spliceosome; ISO:RGD.
DR   GO; GO:0043484; P:regulation of RNA splicing; IMP:UniProtKB.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   CDD; cd12685; RRM_RBM20; 1.
DR   Gene3D; 3.30.70.330; -; 1.
DR   InterPro; IPR000690; Matrin/U1-C_Znf_C2H2.
DR   InterPro; IPR003604; Matrin/U1-like-C_Znf_C2H2.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR034790; RBM20_RRM.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR15592; MATRIN 3/NUCLEAR PROTEIN 220-RELATED; 1.
DR   PANTHER; PTHR15592:SF11; RNA-BINDING PROTEIN 20; 1.
DR   SMART; SM00360; RRM; 1.
DR   SMART; SM00451; ZnF_U1; 2.
DR   SUPFAM; SSF54928; RNA-binding domain, RBD; 1.
DR   PROSITE; PS50102; RRM; 1.
DR   PROSITE; PS50171; ZF_MATRIN; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Metal-binding; mRNA processing; mRNA splicing; Nucleus;
KW   Phosphoprotein; Reference proteome; RNA-binding; Zinc; Zinc-finger.
FT   CHAIN           1..1207
FT                   /note="RNA-binding protein 20"
FT                   /id="PRO_0000419984"
FT   DOMAIN          521..596
FT                   /note="RRM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   ZN_FING         412..446
FT                   /note="U1-type"
FT                   /evidence="ECO:0000255"
FT   ZN_FING         1141..1172
FT                   /note="Matrin-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00130"
FT   REGION          1..58
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          625..686
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          631..650
FT                   /note="RS"
FT                   /evidence="ECO:0000250|UniProtKB:Q5T481"
FT   REGION          722..896
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          951..1110
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1181..1207
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        38..57
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        665..686
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        740..840
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        850..864
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        865..880
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        967..982
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1053..1067
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1071..1103
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         638
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MOD_RES         640
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MOD_RES         643
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MOD_RES         645
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MOD_RES         652
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MOD_RES         729
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MOD_RES         789
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MOD_RES         853
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5T481"
FT   MOD_RES         864
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5T481"
FT   MOD_RES         879
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MOD_RES         881
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MOD_RES         963
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         999
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MOD_RES         1034
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MOD_RES         1046
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MOD_RES         1057
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:35394688,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         1066
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UQS8"
FT   MOD_RES         1078
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UQS8"
FT   MOD_RES         1096
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:35394688,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         1101
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1190
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MOD_RES         1192
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:35394688,
FT                   ECO:0007744|PubMed:22673903"
FT   MUTAGEN         638
FT                   /note="S->A: Impaired ability to regulate alternative
FT                   splicing of Ttn (Titin) mRNAs. Decreased localization to
FT                   the nucleus associated with an increased localization to
FT                   cytoplasmic ribonucleoprotein granules."
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MUTAGEN         638
FT                   /note="S->D: Mimics phosphorylation; does not restore
FT                   nuclear localization."
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MUTAGEN         640
FT                   /note="S->D: Mimics phosphorylation; does not restore
FT                   nuclear localization."
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MUTAGEN         640
FT                   /note="S->G: Impaired ability to regulate alternative
FT                   splicing of Ttn (Titin) mRNAs. Decreased localization to
FT                   the nucleus associated with an increased localization to
FT                   cytoplasmic ribonucleoprotein granules."
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MUTAGEN         643
FT                   /note="S->A: No effect; does not affect ability to regulate
FT                   alternative splicing."
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MUTAGEN         645
FT                   /note="S->A: No effect; does not affect ability to regulate
FT                   alternative splicing."
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MUTAGEN         652
FT                   /note="S->A: No effect; does not affect ability to regulate
FT                   alternative splicing."
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MUTAGEN         729
FT                   /note="S->A: No effect; does not affect ability to regulate
FT                   alternative splicing."
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MUTAGEN         789
FT                   /note="S->A: No effect; does not affect ability to regulate
FT                   alternative splicing."
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MUTAGEN         879
FT                   /note="S->A: No effect; does not affect ability to regulate
FT                   alternative splicing."
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MUTAGEN         881
FT                   /note="S->A: No effect; does not affect ability to regulate
FT                   alternative splicing."
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MUTAGEN         999
FT                   /note="S->A: No effect; does not affect ability to regulate
FT                   alternative splicing."
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MUTAGEN         1034
FT                   /note="S->A: No effect; does not affect ability to regulate
FT                   alternative splicing."
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MUTAGEN         1046
FT                   /note="S->A: No effect; does not affect ability to regulate
FT                   alternative splicing."
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MUTAGEN         1057
FT                   /note="S->A: No effect; does not affect ability to regulate
FT                   alternative splicing."
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MUTAGEN         1096
FT                   /note="S->A: No effect; does not affect ability to regulate
FT                   alternative splicing."
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MUTAGEN         1190
FT                   /note="S->A: No effect; does not affect ability to regulate
FT                   alternative splicing."
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   MUTAGEN         1192
FT                   /note="S->A: No effect; does not affect ability to regulate
FT                   alternative splicing."
FT                   /evidence="ECO:0000269|PubMed:35394688"
FT   CONFLICT        1043
FT                   /note="Q -> R (in Ref. 1; ACD80091)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1207 AA;  130760 MW;  18BBB27389FAA953 CRC64;
     MVLAAAMSQD ADPSGPEQPD RDACIVPGVQ GPPAPQGQQG MQPLPPPLPP PPQPQSSLPQ
     IIQNAAKLLD KNPFSVSSQN PLLTSPASVQ LAQIQAQLTL HRLKMAQTAV TNNTAAATVL
     NQVLSKVAMS QPLFNQLRHP SVLGTTHGPT GVSQHAATVP SAHFPSTAIA FSPPSQAGGP
     GPSVSLPSQP PNAMVVHTFS GVVPQTPAQP AVILSIGKAG PTPATTGFYD YGKANPGQAY
     GSETEGQPGF LPASASAAAS GGVTYEGHYS HTGQDGQATF SKDFYGPSAQ GSHAAGGFPA
     DQAGSMKGDV GGLLQGTNSQ WERPSGFSGQ NKADITAGPG LWAPPASQPY ELYDPEEPTS
     DRAPPAFGSR LNNSKQGFNC SCRRTKEGQA MLSVRPLQGH QLNDFRGLAP LHLPHICSIC
     DKKVFDLKDW ELHVKGKLHA QKCLLFSESA GLRSICATGE GTLSASANST AVYNPTGNED
     YTSTLGTSYA AIPTRAFAQS NPMFPSASSG TNFAQRKGAG RVVHICNLPE GSCTENDVIN
     LGLPFGKVTN YILMKSTNQA FLEMAYTEAA QAMVQYYQEK PALINGEKLL IRMSTRYKEL
     QLKKPGKNVA AIIQDIHSQR ERCMLREADR YGPERPRSRS PMSRSLSPRS HSPPGPSRAD
     WGNGRDSYAW RDEDRETVPR RENGEDKRDR LDVWAHDRKH YPRQLDKAEL DERLEGGRGY
     REKYLKSGSP GPLHSASGYK GREDGYHRKE TKAKLDKHPK QQQQDVPGRS RRKEEARLRE
     PRHPHPEDSG KEEDLEPKVT RAPEGTKSKQ SEKSKTKRAD RDQEGADDKK EGRGAENEAG
     TEEQEGMEES PASVGTQQEG TESSDPENTR TKKGQDCDSG SEPEGDNWYP TNMEELVTVD
     EVGEEDFIME PDIPELEEIV PIDQKDKILP EICPCVTATL GLDLAKDFTK QGETLGNGDA
     ELSPKLPGQV PSTSTSCPND TDMEMAGLNL DAERKPAESE TGLSPEVSNC YEKEARGAEG
     SDVRLAPAAQ RMSSPQPADE RAQQSSPFLD DCKARGSPED GPHEVSPLEE KASPTTESDL
     QSQACQENSR YTETRSLNSR SPEFTEAELK EPLSLPSWEP EVFSELSIPL GVEFVVPRTG
     FYCKLCGLFY TSEEAAKVSH CRSTVHYRNL QKYLSQLAEE GLKETEGVDS PSPERSGIGP
     HLERKKL
//
